Eton Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
12 Contracts & Agreements
- Offer Letter Agreement by and between the Registrant and James Gruber, dated as of March 25, 2022 (Filed With SEC on March 16, 2023)
- Description of Securities of the Registrant (Filed With SEC on March 16, 2021)
- Agreement between Eton Pharmaceuticals, Inc. and Eyemax LLC, dated as of February 18, 2019 (Filed With SEC on May 7, 2019)
- Agreement between Eton Pharmaceuticals, Inc. and Harrow Health Inc., dated as of May 6, 2019 (Filed With SEC on May 7, 2019)
- Agreement between Eton Pharmaceuticals, Inc. and Sintetica SA, dated as of February 8, 2019 (Filed With SEC on May 7, 2019)
- Agreement between Eton Pharmaceuticals, Inc. and Liqmeds Worldwide Limited, dated as of January 23, 2019 (Filed With SEC on May 7, 2019)
- Agreement between Eton Pharmaceuticals, Inc. and Sintetica SA, dated as of February 8, 2019 (Filed With SEC on May 7, 2019)
- Agreement between Eton Pharmaceuticals, Inc. and Bausch Health Ireland Limited (BIRL), dated as of February 18, 2019 (Filed With SEC on May 7, 2019)
- Amendment No. 1 dated August 29, 2018 to Sales/Marketing Agreement (DS-300) dated November 17, 2017 between AL Pharma, Inc. and the Registrant (Filed With SEC on September 25, 2018)
- Offer Letter Agreement by and between the Registrant and W. Wilson Troutman, dated as of June 27, 2017 (Filed With SEC on August 10, 2018)
- Offer Letter Agreement by and between the Registrant and Sean E. Brynjelsen, dated as of May 17, 2017 (Filed With SEC on August 10, 2018)
- Sales/Marketing Agreement (DS-300) dated November 17, 2017 by and among AL Pharma, Inc., SCS National, LLC, Dry Creek Project, LLC and the Registrant (Filed With SEC on August 10, 2018)
